Trial intelligence / Profile preview

Clopidogrel platelet response with omeprazole, rabeprazole, and ranitidine

2009-011543-40Phase 4Terminated

Sponsor
Royal Papworth Hospital
Start
Oct 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of clopidogrel, omeprazole, rabeprazole and ranitidine in coronary arteriosclerosis (3 arms), sponsored by Royal Papworth Hospital. Started Oct 2010; status: terminated.

02

Drugs

clopidogrelomeprazolerabeprazoleranitidine
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on 2009-011543-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011543-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call